tweetindex
ID

VitaDAO 💛

@vita_dao · Ethereum · joined 15 Feb 2021

VitaDAO is a community owned collective funding early stage longevity research,governed by $VITA-holders 🧬

44 352Followers
5 811Following
8 570Posts total
18.2KViews on collected posts

Postingan terbaru

Could protecting the blood–brain barrier help tackle Alzheimer’s? A new study links fibronectin buildup to APOE4-related barrier damage. Reducing it restored barrier function in experimental models. Whether that protects memory remains untested. https://t.co/dsDlM9PEwg 836 views · 9 likes · 1 reposts · 0 replies Open on X →
.@TimDraper , in Cryptonite: “Decentralize the funding. Decentralize the data. Decentralize the right to be wrong in public.” Science works best when it stays provisional - open to challenge, not locked as doctrine. Early longevity biology needs that same room: - competing 1.6K views · 19 likes · 3 reposts · 2 replies Open on X →
Cerrato et al. in Nature Aging: a consensus roadmap toward precision senescence medicine. It comes out of the SENESCENCE2030 meeting in Coimbra. The next step is the unglamorous one: biomarkers and trial designs that can actually test a senolytic. 🧬 https://t.co/8m4FwkuC0D 1.7K views · 6 likes · 0 reposts · 1 replies Open on X →
Agreed the endpoints have to be things people can feel. RAPA-EX-01, co-funded by VitaDAO, tested rapamycin plus exercise in adults 65-85 with a 30-second chair stand as the primary endpoint. It missed, and the result is public. Functional readouts, either way they land. 1.6K views · 7 likes · 1 reposts · 1 replies Open on X →
Online now! Cerrato et al propose a consensus roadmap towards precision senescence medicine, emerging from the SENESCENCE2030 meeting in Coimbra, Portugal earlier this year @marc_dema https://t.co/pgMKLOYtrp 2.9K views · 18 likes · 5 reposts · 0 replies Open on X →
@vitadao @Mykalt45 Good move for the VitaDAo ecosystem 👏 407 views · 2 likes · 1 reposts · 0 replies Open on X →
@vitadao @Mykalt45 true rockstar! 390 views · 2 likes · 1 reposts · 0 replies Open on X →
@vitadao @Mykalt45 congrats! 134 views · 2 likes · 0 reposts · 0 replies Open on X →
Welcoming Michael Torres, Ph.D. (@Mykalt45) as a Core Advisor to VitaDAO. From lab bench → clinic → a ~$300M Eli Lilly acquisition (CrossBridge Bio). Co-founder of ReCode. The scientist behind VitaRNA. Now helping build our crypto × biotech playbook. 💛 8.7K views · 67 likes · 11 reposts · 7 replies Open on X →

Dibandingkan akun berukuran sama

9 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. jangkauan biasa untuk ukurannya, reaksi lebih lemah dari kebanyakan.

Median tayangan1 586akun ini937median untuk 10K–100K
Jangkauan, %3.58%akun ini3.44%median untuk 10K–100K
Interaksi, %0.84%akun ini1.55%median untuk 10K–100K
MetrikAkun iniMedian untuk 10K–100KRasio
Median tayangan per postingan1 5869371.69×
Jangkauan (tayangan ÷ pengikut)3.58%3.44%1.04×
Tingkat interaksi0.84%1.55%0.54×

Akun lain pada rentang ini →   Bandingkan dengan akun lain →   Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

8.7K8 Jul
134
390
407
2.9K3 Sep
1.6K
1.7K
1.6K4 Sep
83614 Sep

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.97%8 Jul
1.49%
0.77%
0.74%
0.84%3 Sep
0.57%
0.41%
1.50%4 Sep
1.20%14 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.55%.

What the audience does

Likes75.0%132 in total
Reposts13.1%23 in total
Replies6.2%11 in total
Quotes0.6%1 in total
Bookmarks5.1%9 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Akun serupa